Characterization and differentiation of equine umbilical cord-derived matrix cells

Stem cells are being evaluated in numerous human clinical trials and are commercially used in veterinary medicine to treat horses and dogs. Stem cell differentiation, homing to disease sites, growth and cytokine factor modulation, and low antigenicity contribute to their therapeutic success. Bone ma...

Full description

Saved in:
Bibliographic Details
Published inBiochemical and biophysical research communications Vol. 362; no. 2; pp. 347 - 353
Main Authors Hoynowski, Steven M., Fry, Madeline M., Gardner, Bryn M., Leming, Matthew T., Tucker, Jeanell R., Black, Linda, Sand, Theodore, Mitchell, Kathy E.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 19.10.2007
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Stem cells are being evaluated in numerous human clinical trials and are commercially used in veterinary medicine to treat horses and dogs. Stem cell differentiation, homing to disease sites, growth and cytokine factor modulation, and low antigenicity contribute to their therapeutic success. Bone marrow and adipose tissue are the two most common sources of adult-derived stem cells in animals. We report on the existence of an alternative source of primitive, multipotent stem cells from the equine umbilical cord cellular matrix (Wharton’s jelly). Equine umbilical cord matrix (EUCM) cells can be cultured, cryogenically preserved, and differentiated into osteo-, adipo-, chondrogenic, and neuronal cell lineages. These results identify a source of stem cells that can be non-invasively collected at birth and stored for future use in that horse or used as donor cells for treating unrelated horses.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0006-291X
1090-2104
DOI:10.1016/j.bbrc.2007.07.182